Humacyte, Inc.

HUMA · Healthcare

$0.57

Markedsværdi: 158.46M USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Humacyte, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire3. sep. 2026, 14.11

Decentralized Clinical Trial Technology Platform Market to Reach $6.12 Billion by 2030 as Virtual Research Adoption Accelerates

GlobeNewswire27. aug. 2026, 17.00

Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight

The Wall Street Journal26. aug. 2026, 23.00

Hakeem Jeffries Confronts Left-Wing Backlash to Jared Kushner Meeting

GlobeNewswire25. aug. 2026, 13.00

AI in Patient Engagement Market Size to Reach USD 45.90 Billion by 2035 as Healthcare Automation Accelerates – SNS Insider

MT Newswires24. aug. 2026, 12.53

Humacyte Plans FDA Filing for Acellular Tissue Engineered Vessel in Dialysis Access